Australia

Froome urine test result in Vuelta double WADA…

By Press Association

Published: 02:36 EST, 13 December 2017 | Updated: 02:36 EST, 13 December 2017

Chris Froome has vowed to provide whatever information is required by the UCI about his use of medication for asthma during the 2017 Vuelta a Espana after a urine test revealed a concentration of Salbutamol double the WADA threshold.

Team Sky said in a statement that Froome experienced “acute asthma symptoms” during the final week of the Vuelta and increased his dosage of Salbutamol, within permissible limits, on doctor’s advice.

The four-time Tour de France winner conducted a urine test on September 7 which revealed a concentration of Salbutamol of 2,000 nanograms, twice the WADA threshold of 1,000.

Chris Froome

Chris Froome

The Team Sky statement said the “use of permissible dosages of Salbutamol can sometimes result in elevated urinary concentrations, which require explanation”.

Froome said: “The UCI is absolutely right to examine test results and, together with the team, I will provide whatever information it requires.”

Sorry we are not currently accepting comments on this article.

Original Article

[contf] [contfnew]

Daily Mail

[contfnewc] [contfnewc]

The post Froome urine test result in Vuelta double WADA… appeared first on News Wire Now.

Related Articles

Back to top button